New treatments for male infertility could widen therapeutic options and possibly shift the treatment burden from women.

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

We take a look at Oxford’s biotech and life sciences hub to discover what makes this historical city a hotspot for scientific ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

As the pharma patent cliff approaches, delve into which important drugs are about to lose exclusivity and how the industry is reacting.

Discover how Treg cell therapies rethink precision medicine for autoimmune diseases like type 1 diabetes, MS, and transplant rejection.

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

And the presence of the Barcelona Science Park, which is the first science park in Spain that is home to three research institutes and more than 70 companies, make the city a viable location for ...

Radioligand therapies gained momentum in 2025 with FDA’s Pluvicto approval. Here’s why 2026 could drive growth and adoption.